Reiter's syndrome
(Redirected from Reiter's Syndrome)
Reiter's Syndrome is a type of reactive arthritis, a condition that causes inflammation in various places in the body. It is named after the German physician Hans Reiter, who first described the condition in 1916.
Symptoms[edit | edit source]
Reiter's Syndrome typically presents with three distinct symptoms: arthritis, conjunctivitis, and urethritis. The arthritis often affects the knees, ankles, and feet, causing pain and swelling. Conjunctivitis, or inflammation of the eye, results in redness, irritation, and discharge. Urethritis, inflammation of the urethra, leads to increased frequency of urination and discomfort during urination.
Causes[edit | edit source]
Reiter's Syndrome is usually triggered by an infection, most commonly a sexually transmitted infection or a gastrointestinal infection. The most common pathogens associated with Reiter's Syndrome are Chlamydia trachomatis, Salmonella, Shigella, Yersinia, and Campylobacter. It is thought that the body's immune response to these infections leads to the inflammation characteristic of Reiter's Syndrome.
Diagnosis[edit | edit source]
Diagnosis of Reiter's Syndrome is primarily based on the presence of the characteristic triad of symptoms. Laboratory tests may be used to identify the triggering infection, and radiography may be used to identify changes in the joints.
Treatment[edit | edit source]
Treatment of Reiter's Syndrome focuses on managing symptoms and treating the triggering infection. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used to reduce inflammation and pain. If NSAIDs are ineffective, corticosteroids or immunosuppressive drugs may be used. Antibiotics are used to treat the triggering infection.
Prognosis[edit | edit source]
The prognosis for Reiter's Syndrome is generally good, with most individuals recovering fully within 3-12 months. However, some individuals may experience recurrent episodes of the disease, and a small percentage may develop chronic, severe arthritis.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD